Diagnostic Value of Thrombocytopenia in Helicobacter pylori Infection Among Pregnant and Non-pregnant Women in Erbil City

Authors

Najat Jabbar Ahmed Berwary, Department of Medical Laboratory Technology,Health Technical College/ Erbil PolytechnicUniversit
Saeed Ghulam, DepartmentofMicrobiology,CollegeofMedicine/ HawlerMedicalUniversity.
Goran Qader Othman, Department of Medical Laboratory Technology,Health Technical College/ Erbil PolytechnicUniversityFollow

How to Cite This Article

Ahmed Berwary, Najat Jabbar; Ghulam, Saeed; and Othman, Goran Qader (2017) "Diagnostic Value of Thrombocytopenia in Helicobacter pylori Infection Among Pregnant and Non-pregnant Women in Erbil City," Polytechnic Journal: Vol. 7: Iss. 3, Article 2.
DOI: https://doi.org/10.25156/ptj.2017.7.3.114

Document Type

Original Article

Abstract

Thrombocytopenia is one of the health problems that faced pregnant women. The formation of antibodies against some of viral and bacterial infection leads to molecular mimicry with the surface of platelets. Hence, it leads to thrombocytopenic purpura. In current study, 421 women including 388 pregnant and 33 non-pregnant women, aged between 18 - 44 years participated in this study. Complete blood count (CBC) and anti H. pylori tests were performed for all participants. A total number of seropositive women for anti H. pylori Ab test (IgG) was 253 (60.1%) including 237 pregnant women and 93 of them were with history of abortion. The results showed significant differences (p<0.000) in mean platelet count between seropositive results for Anti H. pylori Ab test (IgG) and women with seronegative results. Among 253 seropositive women, 199 (78.65%) of them have low platelet count, while only (4.76%) of seronegative women were thrombocytopenic. The cutoff of platelet count for thrombocytopenia set on (150,000 cell/cmm3). ROC analysis revealed good prognostic value of thrombocytopenia for H. pylori infection. This finding concluded that thrombocytopenia can be one of biomarker for H pylori infection among pregnant women.

Publication Date

8-1-2017

References

AHMED, A. F., MOHAMMED-ALI, AND KHALIS B. 2013. Maternal anemia status among pregnant women in Erbil city, Iraq. Middle East Journal of Family Medicine, 11, 23.
APAGIANNAKIS, P., MICHALOPOULOS, C., PAPALEXI, F., DALAMPOURA, D. AND DIAMANTIDIS, M. D. 2013. The role of Helicobacter pylori infection in hematological disorders. European Journal of Internal Medicine, 24, 685–90. BIOMERIEUX, H. P.H. pylori IgG 2004
BOEHLEN, F., HOHLFELD, P., EXTERMANN, P., PERNEGER, T. V. & DE MOERLOOSE, P. 2000. Platelet count at term pregnancy: a reappraisal of the threshold. Obstetrics & Gynecology, 95, 29-33.
EUSEBI, L., H., ROCCO M. Z., AND FRANCO, B. 2014. Epidemiology of Helicobacter pylori Infection. Helicobacter 19 (Suppl. 1): 1–5, 19, 1 - 5.
GASIM, G. I., ALI, N. I., AND ADAM, I. 2014. Helicobacter pylori, anemia, iron deficiency and thrombocytopenia among pregnant women at Khartoum, Sudan. Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene, 108, 380-84.
HOWDEN, C. W., CHEY, W. D., VAKIL, N. B. 2014. Clinical Rationale for Confirmation Testing After Treatment of Helicobacter pylori Infection: Implications of Rising Antibiotic Resistance. Ga s t r o e n t e r o l o g y & H e p a t o l o g y, 10, 1 - 17.
KALSOOM, S., TARAR, SHAHIDA HUSSAIN., AND NAZ, TAHMINA 2013. Anaemia in Pregnancy. Medical Journal;2013, Vol. 20 Issue 5, p736, 20, 736.
KUWANA, M. 2014. Helicobacter pylori -associated immune thrombocytopenia: Clinical features and pathogenic mechanisms. World J Gastroenterol, 21, 714-23. LEONARDO H. EUSEBI, R. M. Z. A. F. B. 2014. Epidemiology of Helicobacter pylori Infection. John Wiley & Sons Ltd, Helicobacter, 19, 1-5.
MĂDĂLINA MOCANU, M. B., MANUELA CIOCOIU, OANA BĂDULESCU Aspects of Viral Involvement in Chronic Immune Thrombocytopenic Purpura. Journal of Biomedical Science and Engineering, 7, 1067-74.
MARTINEZ, N., GARAPATI, K., AND RANDALL, C. 2014. Management of Helicobacter Pylori Infection. Journal of Tropical Diseases, 2, 1 - 3.
MIHĂILĂ R. G., C., R. C., MORAR, S., CERNUȘCĂ-MIȚARIU, M., MARCHIAN, S., AND SABĂU, D. 2014. Severe Persistent Primary Immune Thrombocytopenia, Refractory to Multiple Drugs, including Eltrombopag. Scholars Journal of Medical Case Reports, 2, 24 - 27.
MOCANU, M., BĂDESCU, M., CIOCOIU, M., AND BĂDULESCU, O. 2014. Aspects of Viral Involvement in Chronic Immune Thrombocytopenic Purpura. J. Biomedical Science and Engineering, 7.
OWATANAPANICH, S., WANLAPAKORN, N., TANGSIRI, R. & POOVORAWAN, Y. 2014. Measles-mumps-rubella vaccination induced thrombocytopenia: a case report and review of the literature. The Southeast Asian journal of tropical medicine and public health, 45, 1053-57.
ÖZCIMEN, E. E. 2016. Gestational Thrombocytopenic Patients in Our Center: Analysis of the Patients and Review of the Literature. Gynecology Obstetrics & Reproductive Medicine, 21.
PALUMBO, E., AND BONORA, G. 2008. Cytomegalovirus-Induced Thrombocytopenia in an Immunocompetent Child. Infectious Diseases in Clinical Practice, 16, 54 - 56.
ROESLER, B. M. 2015. Helicobacter pylori Infection and Hematologic Disorders: what do We Really Know? Archives of Clinical Gastroenterology 1 (2): 035-037., 1, 35-37.
TANANDK, H. J. A. G., L. 2012. “Extragastrointestinalmanifestations of Helicobacter pylori infection: facts or myth? A critical review. Journal of Digestive Diseases, vol. 13, no. 7, pp. 342–349, 2012, 13, 342–49.
TIWARI, S. K., KHAN, A. A., HABEEB, A., AND HABIBULLAH, C. M.Chronic idiopathic Thrombocytopenia purpura and Helicobacter pylori eradication 2009 2. 57-59
YEH, J.-J., TSAI, S. , WU, D.-C., WU, J.-Y., LIU, T.-C. AND CHEN, A. 2010. P-selectindependent platelet aggregation and apoptosis may xplain the decrease in platelet count duringHelicobacter pylori nfection. Blood, 115, 4247– 53.